Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 5:12 pm Purchase |
2025-04-10 | 13G | Chimerix, Inc. CMRX |
Glazer Capital, LLC | 4,614,238 4.920% |
4,614,238 (New Position) |
Filing History |
| 2024-02-14 5:01 pm Purchase |
2023-12-31 | 13G | Chimerix, Inc. CMRX |
RA Capital Management, L.P. | 8,800,000 9.900% |
2,298,376 (+35.35%) |
Filing History |
| 2024-02-12 06:06 am Sale |
2023-12-31 | 13G | Chimerix, Inc. CMRX |
Rubric Capital Management LP | 0 0.000% |
-4,779,020 (Position Closed) |
Filing History |
| 2023-09-29 4:54 pm Purchase |
2023-09-19 | 13G | Chimerix, Inc. CMRX |
RA Capital Management, L.P. | 6,501,624 7.300% |
6,501,624 (New Position) |
Filing History |
| 2023-07-07 4:35 pm Sale |
2023-06-30 | 13G | Chimerix, Inc. CMRX |
BlackRock Inc. BLK |
1,146,046 1.300% |
-3,884,821 (-77.22%) |
Filing History |
| 2023-05-02 5:07 pm Sale |
2023-04-30 | 13G | Chimerix, Inc. CMRX |
Rubric Capital Management LP | 4,779,020 5.390% |
-2,720,980 (-36.28%) |
Filing History |
| 2023-02-14 4:11 pm Sale |
2022-12-31 | 13G | Chimerix, Inc. CMRX |
Point72 Asset Management, L.P. | 75,926 0.100% |
-4,472,328 (-98.33%) |
Filing History |
| 2023-02-13 4:05 pm Sale |
2022-12-30 | 13G | Chimerix, Inc. CMRX |
Opaleye Management Inc. | 0 0.000% |
-5,580,000 (Position Closed) |
Filing History |
| 2023-02-13 10:47 am Sale |
2022-12-31 | 13G | Chimerix, Inc. CMRX |
SUVRETTA CAPITAL MANAGEMENT, LLC | 0 0.000% |
-4,948,000 (Position Closed) |
Filing History |
| 2023-02-01 4:54 pm Sale |
2022-12-31 | 13G | Chimerix, Inc. CMRX |
BlackRock Inc. BLK |
5,030,867 5.700% |
-350,369 (-6.51%) |
Filing History |
| 2022-11-10 3:05 pm Purchase |
2022-11-10 | 13D | Chimerix, Inc. CMRX |
Rubric Capital Management LP | 7,500,000 8.510% |
2,700,000 (+56.25%) |
Filing History |
| 2022-07-05 1:39 pm Purchase |
2022-06-17 | 13G | Chimerix, Inc. CMRX |
MOLL PETER | 683 5.200% |
683 (New Position) |
Filing History |
| 2022-05-02 5:15 pm Purchase |
2022-04-21 | 13G | Chimerix, Inc. CMRX |
SUVRETTA CAPITAL MANAGEMENT, LLC | 4,948,000 5.700% |
4,948,000 (New Position) |
Filing History |
| 2022-02-14 4:41 pm Purchase |
2021-12-31 | 13G | Chimerix, Inc. CMRX |
Point72 Asset Management, L.P. | 4,548,254 5.200% |
712,784 (+18.58%) |
Filing History |
| 2022-02-14 09:15 am Purchase |
2021-12-31 | 13G | Chimerix, Inc. CMRX |
Rubric Capital Management LP | 4,800,000 5.530% |
4,800,000 (New Position) |
Filing History |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Chimerix, Inc. CMRX |
BlackRock Inc. BLK |
5,381,236 6.200% |
1,641,237 (+43.88%) |
Filing History |
| 2022-02-03 4:16 pm Sale |
2021-12-31 | 13G | Chimerix, Inc. CMRX |
CANTEX PHARMACEUTICALS INC. | 3,500,000 4.000% |
-6,500,000 (-65.00%) |
Filing History |
| 2022-01-31 8:41 pm Purchase |
2021-12-31 | 13G | Chimerix, Inc. CMRX |
Opaleye Management Inc. | 5,580,000 6.400% |
1,623,500 (+41.03%) |
Filing History |
| 2021-02-23 4:38 pm Purchase |
2021-02-22 | 13G | Chimerix, Inc. CMRX |
Point72 Asset Management, L.P. | 3,835,470 5.000% |
3,669,906 (+2216.61%) |
Filing History |
| 2021-02-12 5:20 pm Purchase |
2020-12-31 | 13G | Chimerix, Inc. CMRX |
Opaleye Management Inc. | 3,956,500 6.320% |
813,600 (+25.89%) |
Filing History |